Patent details
EP1758609 Title: VACCINE AGAINST HPV16 AND HPV18 AND AT LEAST ANOTHER HPV TYPE SELECTED FROM HPV 31, 45 OR 52.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP1758609
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Expired. Art. 36.6 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP05757953.4
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
-
300771
300773
300774
- First Applicant Residence Country:
- Belgium (BE)
- Publications:
Dates
- Filing date:
- 14/06/2005
- Grant date:
- 03/10/2012
- EP Publication Date:
- 03/10/2012
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 03/10/2012
- EP B1 Publication Date:
- 03/10/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- 30/11/2012
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 13/06/2025
- Lapsed By Expiration Date:
- 14/06/2025
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 03/10/2012
- Name:
- GlaxoSmithKline Biologicals SA
- Address:
- Rue de l'Institut 89, 1330 RIXENSART, Belgium (BE)
Domicile Holder
- Name:
- ir. F.A. Geurts c.s.
- From:
- 03/10/2012
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- DEBRUS, Serge GlaxoSmithKline Biologicals S.A.
- Address:
- B-1330 RIXENSART, Belgium (BE)
2
- Name:
- MARTIN, Marie-Therese
- Address:
- B-1330 RIXENSART, Belgium (BE)
3
- Name:
- STEPHEN, Robert John GlaxoSmithKline
- Address:
- BRENTFORD MIDDLESEX TW8 9GS, United Kingdom (GB)
4
- Name:
- STEPHENNE, Jean GlaxoSmithKline Biologicals S.A.
- Address:
- B-1330 RIXENSART, Belgium (BE)
5
- Name:
- WETTENDORFF, Martine, Anne, Cécile
- Address:
- B-1330 RIXENSART, Belgium (BE)
Priority
1
- Priority Patent Number:
- 0413510
- Priority Date:
- 16/06/2004
- Priority Country:
- United Kingdom (GB)
2
- Priority Patent Number:
- 114301
- Priority Date:
- 26/04/2005
- Priority Country:
- United States of America (US)
Classification
- Main IPC Class:
- A61K 39/12;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 25/25
- Publication date:
- 18/06/2025
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 2012/51
- Publication date:
- 19/12/2012
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 2012/41
- Publication date:
- 10/10/2012
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 201240
- Publication date:
- 03/10/2012
- Description:
- Grant (B1)
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 21/05/2024
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 1400 Euro
- Payer:
- Anaqua Services
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 30/11/2012 | Claims | Translated claims | 2 | /3/5/9/7/5/0505757953/docs/ep05757953.4_0_claims20121130.pdf | ||
| 30/11/2012 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /3/5/9/7/5/0505757953/docs/ep05757953.4_1_incomingcorrespondencepaper20121130.pdf | ||
| 30/11/2012 | Outgoing Correspondence | Outgoing Letter | 1 | /3/5/9/7/5/0505757953/docs/ep05757953.4_2_outgoingcorrespondence20121130.pdf |